A detailed history of Envestnet Asset Management Inc transactions in Care Dx, Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 20,406 shares of CDNA stock, worth $437,096. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,406
Previous 14,063 45.1%
Holding current value
$437,096
Previous $218,000 192.2%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$14.41 - $33.99 $91,402 - $215,598
6,343 Added 45.1%
20,406 $637,000
Q2 2024

Aug 08, 2024

BUY
$7.56 - $16.15 $106,316 - $227,117
14,063 New
14,063 $218,000
Q4 2022

Feb 07, 2023

SELL
$10.88 - $20.05 $264,275 - $487,014
-24,290 Reduced 54.69%
20,125 $229,000
Q3 2022

Nov 10, 2022

BUY
$16.06 - $26.39 $24,668 - $40,535
1,536 Added 3.58%
44,415 $756,000
Q2 2022

Aug 03, 2022

SELL
$20.49 - $39.72 $79,193 - $153,517
-3,865 Reduced 8.27%
42,879 $921,000
Q1 2022

May 04, 2022

BUY
$28.19 - $46.6 $252,356 - $417,163
8,952 Added 23.69%
46,744 $1.73 Million
Q4 2021

Feb 04, 2022

SELL
$41.2 - $73.6 $150,091 - $268,124
-3,643 Reduced 8.79%
37,792 $1.72 Million
Q3 2021

Oct 07, 2021

BUY
$59.15 - $91.99 $445,340 - $692,592
7,529 Added 22.21%
41,435 $2.63 Million
Q2 2021

Aug 04, 2021

BUY
$63.02 - $95.11 $391,858 - $591,393
6,218 Added 22.46%
33,906 $3.1 Million
Q1 2021

May 04, 2021

BUY
$57.62 - $95.6 $485,621 - $805,716
8,428 Added 43.76%
27,688 $1.89 Million
Q4 2020

Feb 02, 2021

BUY
$41.43 - $77.09 $73,662 - $137,066
1,778 Added 10.17%
19,260 $1.4 Million
Q3 2020

Oct 09, 2020

SELL
$30.88 - $37.94 $56,757 - $69,733
-1,838 Reduced 9.51%
17,482 $663,000
Q2 2020

Jul 08, 2020

BUY
$18.95 - $35.43 $48,322 - $90,346
2,550 Added 15.21%
19,320 $685,000
Q1 2020

Apr 23, 2020

BUY
$13.94 - $28.25 $233,773 - $473,752
16,770 New
16,770 $366,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.15B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.